focus -WSS

focus

author：Wikipedia 2025-09-27 12:47:23 - browse：569

The back of three medicine containers, a bottle in between two boxes, all showing labels — coverage from STAT — Adobe

After a drug enters the market, it’s up to Food and Drug Administration regulators to ensure its continued safety and efficacy. A recent New York Times story suggests that, in the case of the popular asthma drug Singulair, the FDA fell short — both because the agency delayed action for years on reports from patient advocates and independent groups that the drug could cause suicidal thoughts, and because when it did add a warning label about its potential side effects in 2020, clinicians and patients still weren’t always aware of the risks.

Experts say that the Singulair incident highlights a flawed system, both in the U.S. and globally, for monitoring adverse reactions after a drug is on the market — one that will require extensive changes to address.

“The question is, how safe do you want to be?” said Ameet Sarpatwari, the assistant director of the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital. Ideally, he said, the FDA should be able to both stay on top of safety concerns and avoid unnecessarily restricting access to drugs. “Are we at the right balance? I think there are definitely situations for many drugs where you can say, no, we’re not really at the right balance, and the FDA should be taking a more aggressive stance in promoting patient safety.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Biotech investment managers search for lucrative opportunities

knowledge

WSS

Texas board proposes rules on abortion law emergency exemption

Erich Jarvis studies song birds to learn about human stuttering

Sage's campaign to raise awareness of postpartum depression hits a nerve

Former Georgia lieutenant governor says he received grand jury subpoena

Wegovy cuts risk of cardiovascular events by 20%, study finds

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

hotspot

focus

explore

Supreme Court strikes down use of affirmative action

The painfully weak evidence on taking collagen to treat arthritis

In age of alternative facts, a scholarly course on calling out crap

CRISPR technology availability, affordability needs to be expanded

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Zapping the brain for stroke rehab: Pivotal clinical trial begins

Supreme Court strikes down use of affirmative action

Testing GLP

Psychedelics group wrestles with new pharma identity

Steward Health Care expansion into Malta flopped

focus

This gene therapy has record $4.25 million price. It's saved children.

Lessons Learned: This is why you network to find that industry job you want

Former Georgia lieutenant governor says he received grand jury subpoena

Erich Jarvis studies song birds to learn about human stuttering

What Kate Middleton's cancer revelation might teach the world

CDC launches VaccineFinder tool to locate Covid

knowledge

knowledge

focus

leisure time